New Influx of Humira Biosimilars May Not Drive Immediate Change
As many as 8 to 10 adalimumab biosimilars are anticipated to come on the market this year, giving mainstay drug Humira some vigorous competition.
Source: medscape.com
Stay updated with breaking news from Edwardc Oldfield. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
As many as 8 to 10 adalimumab biosimilars are anticipated to come on the market this year, giving mainstay drug Humira some vigorous competition.